Crossmark

Effectiveness and safety of glucose-lowering drugs as an adjunct to insulin therapy in Chinese patients with type 1 diabetes: a retrospective, observational study

Crossref DOI link: https://doi.org/10.1007/s12020-024-04017-6

Published Online: 2024-09-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

shi, Chenyang

Hu, Shanshan

Lin, Yi

Qin, Yingyi

Tang, Yuanjun

Fan, Guorong

Tang, Zhaosheng
License Information

Text and Data Mining valid from 2024-09-09

Version of Record valid from 2024-09-09
More Information

Article History

Received: 27 May 2024

Accepted: 23 August 2024

First Online: 9 September 2024

Compliance with ethical standards

:

: The authors declare no competing interests.

: The studies involving human participants were reviewed and approved by the Institutional Research Ethics Committee of Shanghai General Hospital (No: 2020KY225).

Document is current

Any future updates will be listed below